Gene–gene interactions in breast cancer susceptibility
Open Access
- 9 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 21 (4), 958-962
- https://doi.org/10.1093/hmg/ddr525
Abstract
There have been few definitive examples of gene–gene interactions in humans. Through mutational analyses in 7325 individuals, we report four interactions (defined as departures from a multiplicative model) between mutations in the breast cancer susceptibility genes ATM and CHEK2 with BRCA1 and BRCA2 (case-only interaction between ATM and BRCA1/BRCA2 combined, P = 5.9 × 10–4; ATM and BRCA1, P= 0.01; ATM and BRCA2, P= 0.02; CHEK2 and BRCA1/BRCA2 combined, P = 2.1 × 10−4; CHEK2 and BRCA1, P= 0.01; CHEK2 and BRCA2, P= 0.01). The interactions are such that the resultant risk of breast cancer is lower than the multiplicative product of the constituent risks, and plausibly reflect the functional relationships of the encoded proteins in DNA repair. These findings have important implications for models of disease predisposition and clinical translation.Keywords
This publication has 21 references indexed in Scilit:
- The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and CancerPublished by Elsevier ,2010
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility allelesNature Genetics, 2006
- The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stabilityOncogene, 2006
- ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility allelesNature Genetics, 2006
- Cancer Risks and Mortality in Heterozygous ATM Mutation CarriersJNCI Journal of the National Cancer Institute, 2005
- CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 StudiesAmerican Journal of Human Genetics, 2004
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Non‐hierarchical logistic models and case‐only designs for assessing susceptibility in population‐based case‐control studiesStatistics in Medicine, 1994